Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic Biomarkers Identification in Esophageal Cancer Based on WGCNA and Single-Cell Analysis. | Dis Markers | 2022 | 36569220 | PubTator, text mining | PubMed |
| Identification of Signature Genes in the PD-1 Relative Gastric Cancer Using a Combined Analysis of Gene Expression and Methylation Data. | J Oncol | 2022 | 36568638 | PubTator, text mining | PubMed |
| Identifying tumor antigens and immune subtypes of gastrointestinal MALT lymphoma for immunotherapy development. | Front Oncol | 2022 | 36568181 | PubTator, text mining | PubMed |
| Identification of key genes in late-onset major depressive disorder through a co-expression network module. | Front Genet | 2022 | 36561317 | PubTator, text mining | PubMed |
| EBV Association with Lymphomas and Carcinomas in the Oral Compartment. | Viruses | 2022 | 36560704 | PubTator, text mining | PubMed |
| Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer. | Genes (Basel) | 2022 | 36553542 | PubTator, text mining | PubMed |
| Comparison of the Single-Cell Immune Landscape of Testudines from Different Habitats. | Cells | 2022 | 36552787 | PubTator, text mining | PubMed |
| Neurological Complications of Conventional and Novel Anticancer Treatments. | Cancers (Basel) | 2022 | 36551575 | PubTator, text mining | PubMed |
| Current Status of Novel Agents for the Treatment of B Cell Malignancies: What's Coming Next? | Cancers (Basel) | 2022 | 36551511 | PubTator, text mining | PubMed |
| Delivery of Drugs into Cancer Cells Using Antibody-Drug Conjugates Based on Receptor-Mediated Endocytosis and the Enhanced Permeability and Retention Effect. | Antibodies (Basel) | 2022 | 36546903 | PubTator, text mining | PubMed |
| Comparison of ischemic stroke diagnosis models based on machine learning. | Front Neurol | 2022 | 36545400 | PubTator, text mining | PubMed |
| MACC1 Correlates with Tumor Progression and Immune Cell Infiltration of Colon Adenocarcinoma and is Regulated by the lncRNA ZFAS1/miR-642a-5p Axis. | J Oncol | 2022 | 36545127 | PubTator, text mining | PubMed |
| Case report: Hematologic malignancies concomitant diagnosis of hairy cell leukemia and chronic lymphocytic leukemia: A rare association. | Front Oncol | 2022 | 36544707 | PubTator, text mining | PubMed |
| Allosteric regulation in STAT3 interdomains is mediated by a rigid core: SH2 domain regulation by CCD in D170A variant. | PLoS Comput Biol | 2022 | 36542668 | PubTator, text mining | PubMed |
| Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma. | Front Immunol | 2022 | 36532059 | PubTator, text mining | PubMed |
| Crosstalk of four kinds of cell deaths defines subtypes of cutaneous melanoma for precise immunotherapy and chemotherapy. | Front Immunol | 2022 | 36532053 | PubTator, text mining | PubMed |
| Diagnostic Accuracy of Image-guided Biopsies for Diagnosis of Metastatic Melanoma in a Real-life Setting. | Acta Derm Venereol | 2022 | 36511331 | PubTator, text mining | PubMed |
| Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options. | Onco Targets Ther | 2022 | 36510607 | PubTator, text mining | PubMed |
| Integrated spatial analysis of gene mutation and gene expression for understanding tumor diversity in formalin-fixed paraffin-embedded lung adenocarcinoma. | Front Oncol | 2022 | 36505794 | PubTator, text mining | PubMed |
| Identification of two robust subclasses of sepsis with both prognostic and therapeutic values based on machine learning analysis. | Front Immunol | 2022 | 36505503 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=48